HONG KONG, Sept. 20, 2016 /PRNewswire/ -- Morrison & Foerster's Hong Kong capital markets team has today successfully
Morrison & Foerster represented the sole sponsor, BOCI Asia Limited, a subsidiary of BOC International Holdings Limited providing investment banking services. Ven Tan, managing partner of Morrison & Foerster's Hong Kong office and head of the Hong Kong capital markets team, led the deal team, which also included Samuel Ng, Benjamin Wang, Grace Yeung, and Euzane Lee.
"We are proud to have played a key role in Jacobson Pharma's IPO, which will enable the company to expand beyond Hong Kong and become a leading brand throughout the Asia Pacific region," Mr. Tan said. "This is just the latest example of MoFo's strength in pharmaceutical sector–related capital markets transactions, which are a key component of our extensive practice offering that also includes a strong expertise in technology deals."
Morrison & Foerster's Hong Kong capital markets team has deep experience acting in the pharmaceutical industry, with deals that include:
Morrison & Foerster is one of the leading capital markets firms in Hong Kong, as well as Greater China. The most respected ranking publications, such as Chambers Global, Chambers Asia, IFLR, and Asia-Pacific Legal 500, have consistently ranked the firm highly for its premier capital markets offerings.
ABOUT MOFOWe are Morrison & Foerster — a global firm of exceptional credentials. Our clients include some of the largest financial institutions, investment banks, Fortune 100, and technology and life sciences companies. The Financial Times has named the firm to its lists of most innovative law firms in North America and Asia every year that it has published its Innovative Lawyers Reports in those regions. In the past few years, Chambers USA has honored MoFo's Bankruptcy and IP teams with Firm of the Year awards, the Corporate/M&A team with a client service award, and the firm as a whole as Global USA Firm of the Year. Our lawyers are committed to achieving innovative and business-minded results for our clients, while preserving the differences that make us stronger.
Amy Merriweather, Public Relations Manager (415) 268-6063, firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/morrison--foerster-completes-ipo-by-hong-kongs-largest-generic-drug-firm-300331544.html
SOURCE Morrison & Foerster
Subscribe to our Free Newsletters!
A patient's struggle with Issacs' syndrome with no cure. Also known as neuromyotonia it is a rare ...
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...View All